These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Viloxazine in the treatment of depressive neurosis: a placebo and standard (imipramine) controlled clinical study.
    Author: Petrie WM, McEvoy JP, Wilson WH, Ban TA, Guy W.
    Journal: Int Pharmacopsychiatry; 1980; 15(3):193-6. PubMed ID: 7016802.
    Abstract:
    In a 4-week double-blind trial, 33 patients with depressive neurosis were randomly assigned to either viloxazine, imipramine or placebo. Statistically significant improvement was observed in all treatment groups. Imipramine exhibited significant improvement earlier in depressive symptoms, while viloxazine showed significant improvement earlier in anxious symptoms. The same frequency of treatment emergent symptoms occurred in the treatment groups. Premature termination as a consequence of adverse reactions was required in only 1 viloxazine and 1 placebo patient.
    [Abstract] [Full Text] [Related] [New Search]